Satsuma Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2023.
  • Satsuma Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. Depreciation for the twelve months ending March 31, 2023 was $418K, a 3.21% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Depreciation for 2022 was $510K, a 29.8% increase from 2021.
  • Satsuma Pharmaceuticals, Inc. annual Depreciation for 2021 was $393K, a 64.4% increase from 2020.
  • Satsuma Pharmaceuticals, Inc. annual Depreciation for 2020 was $239K, a 69.5% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $418K $0 -$92K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $510K $218K +$105K +92.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 $405K $100K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $405K $100K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $405K $92K +$12K +15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $393K $113K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $100K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $100K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $80K +$31K +63.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $49K +$18K +58.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $31K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.